KYOWA KIRIN PHARMACEUTICAL DEVELOPMENT LIMITED
Company number 03297935
- Company Overview for KYOWA KIRIN PHARMACEUTICAL DEVELOPMENT LIMITED (03297935)
- Filing history for KYOWA KIRIN PHARMACEUTICAL DEVELOPMENT LIMITED (03297935)
- People for KYOWA KIRIN PHARMACEUTICAL DEVELOPMENT LIMITED (03297935)
- Charges for KYOWA KIRIN PHARMACEUTICAL DEVELOPMENT LIMITED (03297935)
- More for KYOWA KIRIN PHARMACEUTICAL DEVELOPMENT LIMITED (03297935)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
06 Jan 2020 | PSC07 | Cessation of Kyowa Kirin Services Ltd as a person with significant control on 19 December 2019 | |
02 Jan 2020 | CH01 | Director's details changed for Mr Allan Mark Watson on 31 December 2019 | |
02 Jul 2019 | AA | Full accounts made up to 31 December 2018 | |
23 Apr 2019 | TM01 | Termination of appointment of Harry Thomas Stratford as a director on 31 March 2019 | |
02 Jan 2019 | CS01 | Confirmation statement made on 31 December 2018 with updates | |
07 Sep 2018 | AA | Full accounts made up to 31 December 2017 | |
16 Jan 2018 | PSC02 | Notification of Kyowa Kirin Services Ltd as a person with significant control on 1 January 2018 | |
16 Jan 2018 | PSC07 | Cessation of Kyowa Kirin International Plc as a person with significant control on 1 January 2018 | |
03 Jan 2018 | CS01 | Confirmation statement made on 31 December 2017 with no updates | |
17 Nov 2017 | CH04 | Secretary's details changed for Mcs Formations Limited on 17 November 2017 | |
14 Nov 2017 | AD01 | Registered office address changed from 1st Floor Sackville House 143-149 Fenchurch Street London EC3M 6BL England to 1st Floor Sackville House 143-149 Fenchurch Street London EC3M 6BL on 14 November 2017 | |
14 Nov 2017 | AD01 | Registered office address changed from 235 Old Marylebone Road London NW1 5QT to 1st Floor Sackville House 143-149 Fenchurch Street London EC3M 6BL on 14 November 2017 | |
12 Sep 2017 | AA | Full accounts made up to 31 December 2016 | |
12 Jan 2017 | CS01 | Confirmation statement made on 31 December 2016 with updates | |
06 Sep 2016 | AA | Full accounts made up to 31 December 2015 | |
15 Jun 2016 | TM01 | Termination of appointment of Evelyn Isobel Watson as a director on 9 May 2016 | |
18 Apr 2016 | CERTNM |
Company name changed strakan pharmaceuticals LIMITED\certificate issued on 18/04/16
|
|
18 Apr 2016 | NM06 | Change of name with request to seek comments from relevant body | |
18 Apr 2016 | RESOLUTIONS |
Resolutions
|
|
05 Jan 2016 | AR01 |
Annual return made up to 31 December 2015 with full list of shareholders
Statement of capital on 2016-01-05
|
|
27 Aug 2015 | AA | Full accounts made up to 31 December 2014 | |
26 Feb 2015 | CH01 | Director's details changed for Mr Allan Mark Watson on 17 February 2015 | |
26 Feb 2015 | CH01 | Director's details changed for Dr Harry Thomas Stratford on 17 February 2015 | |
26 Feb 2015 | CH01 | Director's details changed for Mr Andrew Firth Mclean on 1 February 2015 | |
25 Feb 2015 | CH01 | Director's details changed for Dr Harry Thomas Stratford on 1 February 2015 |